A new way to reprogram immune cells and direct them toward anti-tumor immunity
MIT scientists’ discovery yields a potent immune response, could be used to develop a potential tumor vaccine.
MIT scientists’ discovery yields a potent immune response, could be used to develop a potential tumor vaccine.
Hanna Adeyema and Carolina Haass-Koffler discuss the substance use disorder crisis and the future of innovation in the field.
MIT researchers investigate the neural circuits that underlie placebos’ ability to relieve chronic and acute pain.
By unraveling the genetic pathways that help Toxoplasma gondii persist in human cells, Sebastian Lourido hopes to find new ways to treat toxoplasmosis.
The new device, which can be implanted under the skin, rapidly releases naloxone when an overdose is detected.
A mathematical method, validated with experimental data, provides a fast, reliable, and minimally invasive way of determining how to treat critical blood pressure changes during surgery or intensive care.
Propofol, a drug commonly used for general anesthesia, derails the brain’s normal balance between stability and excitability.
By helping microbes withstand industrial processing, the method could make it easier to harness the benefits of microorganisms used as medicines and in agriculture.
The program focused on AI in health care, drawing on Takeda’s R&D experience in drug development and MIT’s deep expertise in AI.
Twelve finalists participated in initiative and 2023-24 MIT-Royalty Pharma Prize Competition, designed to support female biotech pioneers.
New research addresses a gap in understanding how ketamine’s impact on individual neurons leads to pervasive and profound changes in brain network function.
An atlas of human protein kinases enables scientists to map cell signaling pathways with unprecedented speed and detail.
Fifteen new faculty members join six of the school’s academic departments.
New adhesive hydrogel coatings could prolong the lifespan of pacemakers, drug delivery depots, and other medical devices.
Senior Hanjun Lee planned to pursue chemistry at MIT. A course in genetics changed that.